Drug Database
TA

tafluprost + timolol maleate (Tapucom / STN 10111 / STN 1011101)

✓ Approved

Santen Pharmaceutical Co., Ltd. · ADRB1 · 小分子

什么是 tafluprost + timolol maleate?

tafluprost + timolol maleate 是一种小分子,由Santen Pharmaceutical Co., Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Others、Topical。

药物档案

商品名Tapucom, STN 10111, STN 1011101
公司Santen Pharmaceutical Co., Ltd.
药物类别小分子
分子靶点ADRB1, ADRB2, PTGFR
给药途径Others, Topical
状态Approved

作用机制

分子靶点

tafluprost + timolol maleate 作用于 3 个分子靶点:

ADRB1adrenoceptor beta 1 (B1AR, RHR)
ADRB2adrenoceptor beta 2 (ADRBR, B2AR)
PTGFRprostaglandin F receptor (FP)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

tafluprost + timolol maleate 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Eye disordersGlaucoma✓ Approved

相关研究文献

PubMedBMC chemistry2026-11-19

Extractive ion-pair spectrophotometric methods utilizing bromocresol green to estimate chlorpheniramine maleate in pharmaceutical formulations.

Murshed Fatima A FA, Al-Mawri Siham H A SHA, Abdulrahman Sameer A M SAM

Two accurate, sensitive, and cost-effective spectrophotometric methods were developed and validated for the quantitative determination of Chlorpheniramine Maleate (CPM). Method A is based on the formation of a yellow ion-pair complex between CPM and bromocresol green (BCG) in an acidic medium. The resulting complex is extracted into dichloromethane, and its absorbance is measured at 414 nm. Method B involves the dissociation of the yellow-colored CPM-BCG ion-pair complex in a basic medium, leading to the development of a blue color that gives a maximum absorbance at 618 nm. Beer's law was found to be valid within the concentration ranges of 1.00-25.0 µg/mL for method A and 0.20-9.00 µg/mL for method B. The molar absorptivities were determined and found to be 1.76 × 104 and 4.47 × 104 L/(mol.cm) for methods A and B, respectively, with Sandell sensitivity values of 0.0222 and 0.0087 µg/cm². Detection and quantification limits were determined and found to be 0.2049 and 0.6210 µg/mL for method A, and 0.0199 and 0.0603 µg/mL for method B, respectively. The linearity was excellent with correlation coefficients of 0.9995 and 0.9997 for methods A and B. The developed methods were successfully employed to determine CPM in both its pure form and commercial pharmaceutical formulations. The methods were highly precise, with relative standard deviations between 0.24% and 1.85%, and highly accurate, with recovery percentages ranging from 98.14% to 100.8% when applied to pharmaceutical formulations. Statistical comparison with the official USP HPLC method showed no significant differences in accuracy or precision, making the developed methods ideal for routine quality control in resource-limited settings.

PMID 43053190
阅读全文 →
PubMedExpert opinion on drug safety2026-11-18

Ocular hyperemia with netarsudil/latanoprost fixed combination in glaucoma: an exploratory association analysis of tolerability outcomes by prior topical therapy and baseline ocular hyperemia.

Holló Gábor G

This post hoc analysis of MERCURY-3 evaluates factors associated with baseline ocular hyperemia and tolerability outcomes with netarsudil/latanoprost fixed combination (NET/LAT). MERCURY-3 was a prospective, randomized, double-masked, multicenter, Phase 3, European trial. Adults with open-angle glaucoma or ocular hypertension inadequately controlled on topical therapy were randomized to once-daily NET/LAT (n = 218) or bimatoprost/timolol fixed combination (BIM/TIM; n = 212) for 6 months. Patients were stratified by baseline ocular hyperemia status (none vs any grade) and associations with prior treatment, adverse events (AEs), and hyperemia evolution evaluated. In the NET/LAT arm, prior combination therapy was associated with a greater prevalence of baseline ocular hyperemia than prior monotherapy (distribution: p = 0.003). Patients with baseline hyperemia experienced higher rates of AEs (85% vs 63%), ocular treatment-related AEs (74% vs 39%), and conjunctival hyperemia (45% vs 26%) during treatment. Ocular hyperemia remained predominantly mild throughout follow-up, with a more stable severity trajectory linked to prior monotherapy compared with prior combination therapy. No comparable associations were observed with BIM/TIM. Prior treatment complexity and baseline ocular hyperemia status are associated with tolerability outcomes during NET/LAT therapy. These exploratory findings suggest that earlier step-up after monotherapy could be associated with more favorable tolerability. CT.gov identifier: NCT03284853.

PMID 43046532
阅读全文 →
PubMedInternational medical case reports journal2026-11-17

Management of Ahmed Glaucoma Valve Plate Exposure by Plate Removal and Tube Retention: A Case Report.

Alhemyari Mohammed S MS, Al-Hamdi Ibrahim Mohammed IM, Alhemyari Khalid K, Bamashmus Mahfouth A MA

Ahmed glaucoma valve (AGV) implantation is an established option for refractory glaucoma, including neovascular glaucoma (NVG). Exposure of glaucoma drainage device hardware is a serious complication because it increases the risk of infection and may require surgical repair or explantation. A 66-year-old man with diabetes, hypertension, and NVG secondary to diabetic retinopathy developed AGV plate exposure in the right eye two months after implantation. The exposed plate was removed while the tube was retained. The distal open end of the retained tube was positioned subconjunctivally approximately 8 mm posterior to the limbus beneath conjunctival/Tenon tissue. The tube was fixed to the sclera with 10-0 nylon, temporarily ligated with 7-0 Vicryl, and three fenestrations were created proximal to the ligature. Two weeks later, conjunctival wound dehiscence with tube exposure occurred and was repaired with an approximately 4 × 2 mm preserved scleral patch graft. At eight months after the final repair, the eye was quiet, the tube remained covered, and IOP was 14 mmHg while the patient was using dorzolamide-timolol. Tube function was not objectively confirmed. This case suggests that removal of an exposed Ahmed glaucoma valve (AGV) plate with retention of the tube may preserve a potential aqueous drainage pathway. However, subsequent conjunctival wound dehiscence and tube exposure required repair with a preserved scleral patch graft, highlighting the importance of adequate tube coverage, particularly in eyes with compromised conjunctiva. Following repair, tube coverage remained intact and intraocular pressure remained stable during eight months of follow-up, although the independent contribution of the retained tube to IOP control could not be confirmed. Longer follow-up and additional cases are needed to establish the efficacy and safety of this individualized approach.

PMID 43041822
阅读全文 →
PubMedJournal of complementary & integrative medicine2026-11-14

Oleic acid ameliorates some biochemical, molecular, and histological features in a rat model of favism by counteracting the toxicity of vicine and convicine in faba beans.

Koriem Khaled M M KMM, Rostum Arwa S AS

Vicine (V) and convicine (CV) are favism factors in faba beans, moreover oleic acid (OA) has antioxidants and anti-inflammatory activities. The aim is to evaluate if OA can ameliorate biochemical. molecular, and histological features of favism by counteracting toxicity of V and CV in faba beans. 48 male albino rats were split up into eight equal groups, each with six rats as follow; control, OA-treated, V-treated, CV-treated, favism-induced, OA + V-treated, OA + CV-treated, and OA + favism-induced groups administrated 1 mL distilled water, 30 mg/kg OA, 1 % V in rat food, 1 % CV in rat food, injected 5 μL of diethyl maleate and 1/3 of Vicia faba ethanol extract, 30 mg/kg OA prior to V-treated, 30 mg/kg OA prior to CV-treated, and 30 mg/kg OA prior to injection of 5 μL of diethyl maleate and one-third of ethanol extract of V. faba for one month. OA oral administration to favism-induced group restored liver function [serum AST (p=0.0204), ALT (p=0.0210), ALP (p=0.00036), ACP (p=0.0134), γ GT (p=0.0104), total bilirubin (p=0.0203), total protein (p=0.0102), albumin (p=0.0204), globulin (p=0.0139), and liver total protein (p=0.00071)], blood parameters [Hb (p=0.0035), Hct (p=0.0045), RBCs (p=0.0203), WBCs (p=0.0107), MCV (p=0.01750), MCH (p=0.02141), PLT (p=0.00341), serum glucose (p=0.00109) and G6PD (p=0.0213)], and antioxidants [Glutathione (p=0.0102 and 0.0026), SOD (p=<0.00001 and <0.00001), GPx (p=<0.00001 and <0.00001), MDA (p=0.0203 and 0.0012)] in liver and blood while decreased serum and liver inflammatory markers [TNF-α (p=<0.00001 and <0.00001), IL-1β (p=0.000062 and 0.000018), IL-6 (p=<0.00001 and <0.00001), and IL-10 levels (p=0.0037 and 0.000071)], prevented liver DNA breakdown, increased blood and liver nuclear factor-kB (p=0.0201 and 0.0017) and sodium/potassium-ATP activity (p=0.0102 and 0.0026), and ameliorated liver histology compared to favism-induced group to approach the normal values. OA ameliorated hemoglobin, hematocrite, red and white blood cells, serum glucose-6-phosphate dehydrogenase, liver enzymes, blood and liver glutathione, superoxide dismutase, and malondialdehyde, serum and liver tumor necrosis factor-α, interleukin-1 beta, blood and liver nuclear factor-kappa B level and sodium/potassium-ATPase activity, prevented hepatic DNA breakdown, hepatocytes compressed and edema in the liver tissue.

PMID 43031446
阅读全文 →
PubMedJournal of economic entomology2026-11-10

Managing multi-resistant German cockroaches with dinotefuran: toxicity, bait performance, secondary transfer, and residual effectiveness.

Huang Chun-Ting CT, Chen Mei-Er ME, Lee Chow-Yang CY, Neoh Kok-Boon KB

The German cockroach, Blattella germanica (Linnaeus), has evolved resistance to multiple insecticide classes, threatening the effectiveness of management programs. Although dinotefuran has become an alternative for cockroach management, its efficacy against field populations with documented resistance to multiple insecticide classes remains poorly understood. We evaluated dinotefuran susceptibility in 11 field populations from Taiwan and assessed the efficacy of commercial gel bait and residual spray formulations. Topical bioassays revealed reduced susceptibility in 8 populations at the 1× LD95 diagnostic dose, whereas only 2 exhibited reduced susceptibilities at the 3× LD95. Synergism assays demonstrated that piperonyl butoxide completely restored susceptibility in resistant populations, suggesting cytochrome P450 monooxygenases as the detoxification mechanism. Additional effects of S,S,S-tributyl phosphorotrithioate and diethyl maleate further suggested that esterases and glutathione-S-transferases also contributed to resistance in some populations. Despite reduced susceptibility in topical bioassays, the commercial dinotefuran gel bait remained highly effective against field populations. Its efficacy persisted after aging, and secondary toxicant transfer through necrophagy caused substantial additional mortality when alternative food was unavailable. Residual sprays induced rapid knockdown and high 24-h mortality in adult males, but efficacy declined with residue age, particularly against adult females after 14 days. These findings indicate that dinotefuran formulations remain useful for German cockroach management despite variation in susceptibility among field populations. Integrating dinotefuran bait with sanitation and rotating insecticides with different modes of action may improve control while helping to delay resistance evolution. Timely reapplication of residual dinotefuran spray is necessary to maintain satisfactory control.

PMID 43008798
阅读全文 →
PubMedMacromolecular rapid communications2026-11-09

Polyurethane Toughened Polystyrene With In-Situ Compatibilization and Controlled Hierarchical Microphase Structure by "One-Pot" Cascade Radical and Step-Growth Polymerizations.

Wang Xinpeng X, Wang Guochen G, Zhao Dan D, Cao Han H et al.

The microphase structure of multicomponent and multiphase polymers plays a critical role in determining their properties. A one-pot strategy integrating radical and step-growth polymerizations is developed to prepare polyurethane (PU)/polystyrene (PS) alloy (PUS) with a high-impact polystyrene (HIPS)-like salami morphology. Di-(6-hydroxylhexyl) maleate (HMH) is introduced as a dual-role monomer to form PS-g-PU as a compatibilizer in situ. When dibutyltin dilaurate (DBTDL) was initially mixed with poly(tetramethylene glycol), HMH, 4,4'-methylenebis(phenyl isocyanate), and styrene, delaying benzoyl peroxide (BPO) addition allowed the PU particles (0.1∼0.3 µm) to aggregate into larger PU microdomains. In contrast, when BPO was initially mixed with the monomers, delaying DBTDL addition promoted the formation of PS-grafted HMH, followed by their incorporation into PU chains and forming a salami-like morphology. The optimized PUS exhibited a notched impact and tensile strengths of 10.1 kJ/m2 and 45.5 MPa, respectively (9.4 kJ/m2 and 30.9 MPa for commercial HIPS). This work provides a one-pot route for coupling chain-growth and step-growth polymerizations to prepare PUS with controlled phase structures and in-situ compatibilization.

PMID 43000230
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多tafluprost + timolol maleate